Latest News and Press Releases

New York, July 30, 2025 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) today announced $1.1 million in grants to four organizations working to expand access to prevention,...

TEMECULA, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., recognized as the nation’s most trusted specialty drug distributor and diversified healthcare company, is celebrating 37...

New York, March 19, 2025 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) is hosting a webinar on “Medicaid’s Ongoing Critical Role in the U.S. Response to the Opioid and...

New York, March 13, 2025 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) has awarded a $65,702 grant to Tradeoffs, a nonprofit health care news organization, to support new...

Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to distribute multiple life-saving opioid overdose emergency...

Millburn, NJ, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Thousands of residents from New Jersey and throughout the country, including many health care professionals, are now better informed and prepared to...

TEMECULA, Calif, Dec. 10, 2024 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, announces the launch...

New York, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The opioid and overdose crisis continues to exact a heavy toll on at-risk populations across the United States. Among adolescents aged 13-18, overdose...

Dallas, TX, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading developer of wearable neurostimulation devices, proudly announces the recent achievement of ISO 13485:2016 and MDSAP Quality...

Phoenix, AZ, Nov. 04, 2024 (GLOBE NEWSWIRE) -- In the recently issued, “Statement on Fentanyl “Exposure” Laws,” the American College of Medical Toxicology (ACMT) expresses concern regarding...